HomeLegal DirectoryFDA 510(k) — surgical robots

In effect Moderate protection

FDA Premarket Notification (510(k)) Pathway for Robotically-Assisted Surgical Devices

United States · 21 U.S.C. § 360(k); 21 C.F.R. Part 807

Robotically-assisted surgical devices (RASD) — like Intuitive's da Vinci or Stryker's Mako — are FDA-regulated medical devices. Most clear the market through the 510(k) pathway by showing substantial equivalence to a predicate device. The FDA issued a 2019 safety communication and continues to police off-label robotic mastectomy and AI-software updates under its evolving 'Predetermined Change Control Plan' authority.

Technical detail

21 U.S.C. § 360(k); 21 C.F.R. § 807 subpart E. RASD product codes NAY (Class II). FDA Feb. 28, 2019 safety communication on robotic mastectomy; FDA AI/ML PCCP guidance finalized Dec. 2024 under FDORA § 3308 (21 U.S.C. § 360e-4).

Who is protected: Surgical patients and providers using robotically-assisted devices

Who must comply: Manufacturers of robotically-assisted surgical and AI-enabled medical devices

Key facts

JurisdictionUnited States
LevelFederal
StatusIn effect
Protection strengthModerate protection
Effective date1976-05-28
Enacted1976-05-28
Citation21 U.S.C. § 360(k); 21 C.F.R. Part 807
Enforced byU.S. Food and Drug Administration (CDRH)
Private right of actionNo — agency enforcement only
PenaltiesWarning letters; civil monetary penalties; injunction; criminal prosecution under FDCA
Topicshealthcare AI · consumer protection · automated decision-making
Last verified2026-06-17
Official sourceFDA Safety Communication: Robotically-Assisted Surgical Devices (FDA.gov) ↗

More AI rules in United States

Related healthcare AI rules elsewhere

See something wrong or out of date? Submit a correction — every entry must carry a verifiable official source.